Table 37 (abstract P344). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two
JIA patients N = 13,602 n (%) | Orencia-treated patients n = 343 n (%) | Other biologic-treated patients n = 3507 n (%) | |
|---|---|---|---|
Female, n (%) | 9679 (71.2) | 284 (82.8) | 2563 (73.1) |
Age, mean (SD) | 10.4 (4.6) | 12.0 (3.8) | 11.2 (4.4) |
Asthma, n (%) | 873 (6.4) | 28 (8.2) | 187 (5.3) |
Cardiovascular disease, n (%) | 618 (4.5) | 24 (7.0) | 171 (4.9) |
Uveitis, n (%) | 1302 (9.6) | 32 (9.3) | 467 (13.3) |
Biologic DMARDs, n (%) | 1732 (12.7) | 168 (49.0) | 1564 (44.6) |
Non-biologic DMARDs, n (%) | 3321 (24.4) | 156 (45.5) | 1548 (44.1) |
Inpatient visits, mean (SD) | 0.08 (0.36) | 0.10 (0.45) | 0.09 (0.38) |
Outpatient visits, mean (SD) | 8.70 (7.8) | 11.66 (10.4) | 9.6 (8.5) |